Protection against amebic liver abscess formation in the severe combined immunodeficient mouse by human anti-amebic antibodies

American Journal of Tropical Medicine and Hygiene

Volumn 55, Issue 3, 1996, Pages 330-332

  Seydel, Karl B ^a   Braun, Kari L ^a   Zhang, Tonghai ^a   Jackson, Terry F H G ^b   Stanley Jr , Samuel L ^a,c  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b S African Med Res Cncl (Durban)   (South Africa)

^c Campus Box 8051 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTOZOON ANTIBODY;

AMEBIASIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIPROTOZOAL ACTIVITY; ARTICLE; COMBINED IMMUNODEFICIENCY; ENTAMOEBA HISTOLYTICA; HUMAN; IMMUNOTHERAPY; INFECTION PREVENTION; INFECTION SENSITIVITY; LIVER ABSCESS; MOUSE; NONHUMAN; PASSIVE IMMUNIZATION;

ANIMALIA; ENTAMOEBA HISTOLYTICA; PROTOZOA;

EID: 0029744271     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.1996.55.330     Document Type: Article

References (12)

1. Walsh J, 1988. Prevalence of Entamoeba histolytica infection. Ravdin JI, ed. Amebiasis, Human Infection by Entamoeba histolytica. New York: John Wiley Sons, 93-105.
2. Salata RA, Ravdin JT, 1986. Review of the human immune mechanisms directed against Entamoeba histolytica. Rev Infect Dis 8: 261-272.
3. deLeon A, 1970. Pronostico tardio en el absceso hepatico amibiano. Arch Invest Med de Mexico 1: s205-206.
4. Cieslak PR, Virgin HW IV, Stanley SL Jr, 1992. A severe combined immunodeficient (SCID) mouse model for infection with Entamoeba histolytica. J Exp Med 176: 1605-1609.
5. Zhang T, Cieslak PR, Foster L, Kunz-Jenkins C, Stanley SL Jr, 1994. Antibodies to the serine rich Entamoeba histolytica protein (SREHP) prevent amebic liver abscess in severe combined immunodeficient (SCID) mice. Parasite Immunol 16: 225-230.
6. Diamond LS, Harlow DR, Cunnick CC, 1978. A new medium for the axenic cultivation of Entamoeba histolytica and other Entamoeba. Trans R Soc Trop Med Hyg 72: 431-432.
7. Ravetch JV, Kinet J, 1991. Fc receptors. Annu Rev Immunol 9: 457-492.
8. Stanley SL Jr, Blanchard JL, Johnson N, Foster L, Kunz-Jenkins C, Zhang T, Tian K, Cogswell FB, 1995. Immunogenicity of the recomhinant serine rich Entamoeba histolytica protein (SREHP) in African green monkeys. Vaccine 13: 947-951.
9. Zhang T, Cieslak PR, Stanley SL Jr, 1994. Protection of gerbils from amebic liver abscess by immunization with a recombinant Entamoeha histolytica antigen. Infect Immun 62: 1166-1170.
10. Zhang T, Stanley SL Jr, 1994. Protection of gerbils from amebic liver abscess by immunization with a recombinant protein derived from the 170 kDa surface adhesin of Entamoeba histolytica. Infect Immun 62: 2605-2608.
11. Soong C-JG, Torian BE, Abd-Alla MD, Jackson TFHG, Gathiram V, Ravdin JI, 1995. Protection of gerbils from amebic liver abscess by immunization with recombinant Entamoeba histolytica 29-kilodalton antigen. Infect Immun 63: 472-477.
12. Soong C-JG, Kain KC, Abd-Alla MD, Jackson TFHG, Ravdin JI, 1995. A recombinant cysteine-rich section of the Entamoeba histolytica galactose-inhibitable lectin is efficacious as a subunit vaccine in the gerbil model of amebic liver abscess. J Infect Dis 171: 645-651.